Evidence map›Paper›PMID 37938368›Full record

ArticleCancer immunology, immunotherapy : CII2023

Spatial immune composition of tumor microenvironment in patients with pancreatic cancer.

Eline S Zwart, Thomas van Ee, Alsya J Affandi, Lenka N C Boyd, Ernesto Rodriguez, Joke M M den Haan, Arantza Farina, Nicole C T van Grieken, Laura L Meijer, Yvette van Kooyk and 2 more

Open access · hybridAbstract read
In one paragraph

Article in Cancer immunology, immunotherapy : CII, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Imaging the fate of CAR-T cellsFrontiers in immunology · 2026
    Review
  4. Article
  5. Review
  6. Article
  7. Exploring CD169Vaccines · 2025
    Review
  8. Review
  9. Review
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 1 country.

Eline S ZwartDepartment of Surgery, Amsterdam UMC, Location Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.
Thomas van EeCancer Center Amsterdam, Amsterdam, The Netherlands.
Alsya J AffandiCancer Center Amsterdam, Amsterdam, The Netherlands.
Lenka N C BoydDepartment of Surgery, Amsterdam UMC, Location Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.
Ernesto RodriguezCancer Center Amsterdam, Amsterdam, The Netherlands.
Joke M M den HaanCancer Center Amsterdam, Amsterdam, The Netherlands.
Arantza FarinaCancer Center Amsterdam, Amsterdam, The Netherlands.
Nicole C T van GriekenCancer Center Amsterdam, Amsterdam, The Netherlands.
Laura L MeijerDepartment of Surgery, Amsterdam UMC, Location Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.
Yvette van KooykCancer Center Amsterdam, Amsterdam, The Netherlands.
Reina E Mebius *Cancer Center Amsterdam, Amsterdam, The Netherlands.
Geert Kazemier *Department of Surgery, Amsterdam UMC, Location Vrije Universiteit Amsterdam, Amsterdam, The Netherlands. G.kazemier@amsterdamumc.nl.
Cancer Center Amsterdam · NLVrije Universiteit Amsterdam · NLAmsterdam University Medical Centers · NLUniversity of Amsterdam · NL

Funding

European Research Council ERC-339977-Glycotreat
6 · The paper itself

Abstract

This study examined the composition of the immune microenvironment at different sites within resected pancreas specimens from patients with pancreatic ductal adenocarcinoma (PDAC). Therefore, single-cell suspensions were made from fresh tumor and non-tumorous tissue. Fourteen patients were included from whom twelve PDAC and five non-tumorous samples were obtained. These samples were analyzed with a nineteen marker panel on the Aurora spectral flow cytometer. Furthermore, slides from formalin-fixed paraffine PDACs of eight additional patients were stained with eight markers and analyzed by multispectral imaging. These corresponded to central tumor, periphery of the tumor, i.e., invasive front and resected lymph node and were divided into tumor and adjacent tissue. In the single-cell suspension, a decreased ratio between lymphoid and myeloid cells and between M1 and M2 macrophages was observed in the tumor tissue compared to non-tumorous tissue. Furthermore, an increase in CD169 + macrophages in patients undergoing neoadjuvant therapy was found. Using immunofluorescence, more macrophages compared to T cells were observed, as well as a lower ratio of CD8 to M2 macrophage, a higher ratio of CD4-CD8 T cells and a higher ratio of immune-suppressive cells to pro-inflammatory cells in the PDAC area compared to the adjacent non-tumorous tissue. Finally, there were more immune-suppressive cells in the central tumor area compared to the invasive front. In conclusion, we show a gradient in the immune-suppressive environment in PDAC from most suppressive in the central tumor to least suppressive in distant non-tumorous tissue.

Indexed as

Carcinoma, Pancreatic DuctalPancreatic NeoplasmsHumansPancreasT-LymphocytesTumor MicroenvironmentImmunologyNeoadjuvant therapyPancreatic cancerTumor microenvironment

Identifiers

PMID37938368
PMCPMC10700423
OpenAlexW4388490149

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.